And we have developed and put in place a policy with authors and editors to clarify how tools like the ChatGPT can be used, how it can be used as a tool to enhance articles, but also transparently stating how it’s been used, how we disclose, how it’s being disclosed and used is becoming standardized within the industry. And the way I see it is this is going to continue to evolve. Whether then that specifically means that certain types of tools, like you said, preprints and others might have €“ be seen to have a different value if they haven’t been peer-reviewed, if they haven’t been rigorously edited and checked for different tools and methodologies. I think that remains to be seen. I still believe, again, that the value and importance of trusted contents and brands in this kind of environment should not go down.
That’s probably my conclusion on that, but it’s going to continue to evolve. We’re already in the process of testing and experimenting with the technology for our internal processes for our own processes, our own word processing as well as our own technology tools for our own employees to see if there are ways that we can enhance it, but without using it as a product itself.
Nick Luff: So Tom, your question on the Exhibitions schedule for 2023. Outside of China, almost all the Exhibitions are scheduled to run in their normal slots, but we’ll see whether that’s possible, and we’ve become very good at being flexible and adapting if we need to. Your question is on M&A and which business areas would it €“ would that fall into. I mean the first thing to say is all our businesses are focused primarily on organic development, of course. We will use acquisitions and make acquisitions where we see ways of enhancing and accelerating the organic development. If you look back over the last few years, the Risk division has had more of the acquisition capital, but that’s a product of opportunity and the dynamics of that particular segment. We’re certainly willing and actively always looking in all four business areas.
Operator: Thank you. We will take our next question from Matthew Walker from Credit Suisse. Your line now has been opened. Please go ahead.
Matthew Walker: Thanks guys, and good morning everyone. Yes, it’s Matthew Walker from Credit Suisse. I also had a question on GPT, which is you mentioned how it can be used in a defensive mode to enhance your products for customers and also to benefit your staff internally to, sort of save time, et cetera. What do you see from the possibility of it being used offensively against you from start-ups and €“ or maybe even larger companies? You’ve got like a lot of deep data in all the different divisions. To what extent can GPT pull out that data with or without your consent? And how easy would it be for a rival company to build some effective products based on that technology and start charging for them? So, if you could just give us a bit of color on how that technology might or might not be able to be used against you?
The second thing is, could you give a bit more color? You answered a little bit, but I just wanted a bit more color on Risk transaction outlook for this year. I mean it’s obvious that reinsurance is recovering. Can you give us some products or a feel for the different types of products? You mentioned personal finance, but could you mention some different products which might be experiencing a slowdown in the other side, the noninsurance side, of transactions and give us a sense of where things may or may not be vulnerable and what current growth rates are like? And then finally, on Exhibitions. Could you tell us what your re-bookings rate was both the first half and second half?
